What is Human Immunodeficiency Virus (HIV)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is HIV?

HIV (Human Immunodeficiency Virus) is a retrovirus that specifically targets and destroys CD4+ T lymphocytes, progressively weakening the immune system and ultimately leading to AIDS (Acquired Immunodeficiency Syndrome) if left untreated. 1, 2

Viral Classification and Structure

  • HIV is an RNA retrovirus belonging to the Lentivirus genus that contains three major genes encoding capsid proteins, enzymes, and envelope glycoproteins 2
  • Two distinct types exist: HIV-1 (more common in the United States) and HIV-2, with HIV-1 further categorized into groups M, O, N, and P 2
  • The virus has a unique life cycle involving reverse transcription of RNA to DNA, which then integrates into the host cell's genome 3

Mechanism of Immune Destruction

  • HIV's primary cellular target is the CD4+ T lymphocyte, which serves as the key component for generating and regulating immune responses 4
  • The virus binds to cells through the CD4 membrane glycoprotein receptor, found predominantly on helper T lymphocytes and cells of the monocyte/macrophage lineage 4
  • HIV destroys CD4 cells through direct viral cytotoxicity and indirectly through host immune responses against infected cells 4
  • Macrophage-lineage cells are generally not destroyed but serve as viral reservoirs, contributing to persistent infection 4
  • The virus infects less than 1 in 10,000 T cells, yet causes progressive immune depletion over years 5

Natural History of Infection

  • Initial transmission is generally inefficient, followed by an acute phase of intense viral replication and dissemination to lymphoid tissues 6
  • A chronic, often asymptomatic phase follows, characterized by sustained immune activation and ongoing viral replication 6
  • Without treatment, infection progresses over an average of 8 years from initial infection to AIDS, marked by severe CD4+ T cell depletion 1, 5
  • The CNS becomes infected during the primary stage and remains infected throughout the course of disease in most untreated individuals 1

Clinical Spectrum

  • Early infection may be asymptomatic despite active viral replication and immune system damage 6
  • Progressive disease manifests as asymptomatic neurocognitive impairment, HIV-associated mild neurocognitive disorder (MND), and eventually HIV-associated dementia (HAD) 1
  • Advanced AIDS is characterized by severe opportunistic infections including cryptococcal meningitis and primary CNS lymphoma 1
  • AIDS is defined by severe T cell depletion and over 20 conventional degenerative and neoplastic diseases 5

Diagnostic Detection

  • HIV infection can be detected through HIV RNA testing (becomes positive first, typically 3-5 days before p24 antigen), p24 antigen detection, and antibody testing 2
  • Antibody testing typically becomes positive within the first four weeks after exposure, with ≥95% of patients showing detectable antibodies within 6 months 2, 7
  • Standard diagnosis involves repeatedly reactive immunoassay followed by confirmatory Western blot or immunofluorescent assay, with sensitivity and specificity greater than 99% 2

Disease Monitoring Parameters

  • CD4+ T cell counts and HIV viral load are the primary markers used to determine disease stage and guide treatment decisions 2
  • CD4 count stratification includes three categories: ≥500 cells/mm³, 200-500 cells/mm³, and <200 cells/mm³ 2
  • Viral suppression is defined as viral load persistently below the level of detection, typically 20-80 copies/mL 2

Treatment Impact

  • Combination antiretroviral therapy (cART) suppresses viral replication and viremia, prevents or delays progression to AIDS, reduces transmission rates, and lowers HIV-associated mortality and morbidity 8
  • However, cART does not eliminate HIV—an enduring pool of infected resting memory CD4+ T cells (latent HIV reservoir) is established early, requiring lifelong adherence to prevent viral rebound 8
  • Where HAART is widely available, there has been profound reduction in the incidence and severity of HAD and major CNS opportunistic infections 1

Key Distinguishing Features from Other Viruses

  • HIV is not HTLV-I or HTLV-II (Human T-Lymphotropic Viruses), which are different retroviruses that do not cause AIDS 1
  • Unlike typical viral infections, HIV causes disease only after the onset of antiviral immunity (positive antibody test), following long and unpredictable asymptomatic intervals averaging 8 years 5
  • The virus can exist in latent or chronic form, with mechanisms of viral persistence and conversion to productive infection still under investigation 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Human Immunodeficiency Virus (HIV) Definition and Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Virology, immunology, and clinical course of HIV infection.

Journal of consulting and clinical psychology, 1990

Research

Immunological features of human immunodeficiency virus disease.

Bailliere's clinical haematology, 1990

Research

Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.

Proceedings of the National Academy of Sciences of the United States of America, 1989

Research

Pathogenic mechanisms of HIV disease.

Annual review of pathology, 2011

Guideline

HIV Diagnosis and Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Immune Control of HIV.

Journal of life sciences (Westlake Village, Calif.), 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.